Hypertension in Continuous Ambulatory Peritoneal Dialysis Patients: What do we know and What can we do about It?
| Autor: | Hyang Kim, Jhoong S. Cheigh |
|---|---|
| Rok vydání: | 1999 |
| Předmět: |
medicine.medical_specialty
business.industry Potential risk medicine.medical_treatment media_common.quotation_subject Continuous ambulatory peritoneal dialysis Cardiovascular risk factors 030232 urology & nephrology General Medicine 030204 cardiovascular system & hematology Dialysis patients Peritoneal dialysis 03 medical and health sciences 0302 clinical medicine Nephrology medicine Hemodynamic stability Intensive care medicine business Vigilance (psychology) media_common Cardiovascular mortality |
| Zdroj: | Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 19:138-143 |
| ISSN: | 1718-4304 0896-8608 |
| DOI: | 10.1177/089686089901902s22 |
| Popis: | Despite many advantages of CAPD in maintaining hemodynamic stability, approximately 50% -60% of CAPD patients have hypertension and require antihypertensive treatment. ACE inhibitors and betablockers are the preferred first-line antihypertensive drugs in these patients, but some patients may require additionallong-acting calcium antagonists to enhance antihypertensive effects. Despite antihypertensive treatment, many patients often fail to maintain BP within optimal ranges, and this fact may contribute to the high incidences of cardiovascular morbidity an d mortality. Vigilance is clearly desirable by the patient and the physician to maintain BP within target ranges most of the time. Because dialysis patients also have many other cardiovascular risk factors, the strategy to decrease cardiovascular mortality should be a combined effort targeting all potential risk factors at the same time. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|